166 related articles for article (PubMed ID: 23284864)
1. Fetuin, matrix-Gla protein and osteopontin in calcification of renal allografts.
Lorenzen JM; Martino F; Scheffner I; Bröcker V; Leitolf H; Haller H; Gwinner W
PLoS One; 2012; 7(12):e52039. PubMed ID: 23284864
[TBL] [Abstract][Full Text] [Related]
2. Vascular calcification is not related to serum fetuin-A and osteopontin levels in hemodialysis patients.
Ulutas O; Taskapan MC; Dogan A; Baysal T; Taskapan H
Int Urol Nephrol; 2018 Jan; 50(1):137-142. PubMed ID: 29134617
[TBL] [Abstract][Full Text] [Related]
3. Inhibitors of calcification in blood and urine.
Schlieper G; Westenfeld R; Brandenburg V; Ketteler M
Semin Dial; 2007; 20(2):113-21. PubMed ID: 17374084
[TBL] [Abstract][Full Text] [Related]
4. Serum levels of calcification inhibitors in patients with intracerebral hemorrhage.
Acar A; Cevik MU; Arıkanoglu A; Evliyaoglu O; Basarılı MK; Uzar E; Ekici F; Yucel Y; Tasdemir N
Int J Neurosci; 2012 May; 122(5):227-32. PubMed ID: 22115341
[TBL] [Abstract][Full Text] [Related]
5. Gla-rich protein acts as a calcification inhibitor in the human cardiovascular system.
Viegas CS; Rafael MS; Enriquez JL; Teixeira A; Vitorino R; Luís IM; Costa RM; Santos S; Cavaco S; Neves J; Macedo AL; Willems BA; Vermeer C; Simes DC
Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):399-408. PubMed ID: 25538207
[TBL] [Abstract][Full Text] [Related]
6. Serum levels of calcification inhibition proteins and coronary artery calcium score: comparison between transplantation and dialysis.
Mazzaferro S; Pasquali M; Pugliese F; Barresi G; Carbone I; Francone M; Sardella D; Taggi F
Am J Nephrol; 2007; 27(1):75-83. PubMed ID: 17259697
[TBL] [Abstract][Full Text] [Related]
7. Fetuin-A function in systemic mineral metabolism.
Herrmann M; Kinkeldey A; Jahnen-Dechent W
Trends Cardiovasc Med; 2012 Nov; 22(8):197-201. PubMed ID: 22902178
[TBL] [Abstract][Full Text] [Related]
8. Circulating calcification inhibitors and vascular properties in children after renal transplantation.
van Summeren MJ; Hameleers JM; Schurgers LJ; Hoeks AP; Uiterwaal CS; Krüger T; Vermeer C; Kuis W; Lilien MR
Pediatr Nephrol; 2008 Jun; 23(6):985-93. PubMed ID: 18286307
[TBL] [Abstract][Full Text] [Related]
9. Lanthanum acetate inhibits vascular calcification induced by vitamin D3 plus nicotine in rats.
Zhou YB; Jin SJ; Cai Y; Teng X; Chen L; Tang CS; Qi YF
Exp Biol Med (Maywood); 2009 Aug; 234(8):908-17. PubMed ID: 19546357
[TBL] [Abstract][Full Text] [Related]
10. Renal osteodystrophy: alpha-Heremans Schmid glycoprotein/fetuin-A, matrix GLA protein serum levels, and bone histomorphometry.
Coen G; Ballanti P; Balducci A; Grandi F; Manni M; Mantella D; Pierantozzi A; Ruggeri M; Sardella D; Sorbo G; Bonucci E
Am J Kidney Dis; 2006 Jul; 48(1):106-13. PubMed ID: 16797392
[TBL] [Abstract][Full Text] [Related]
11. Inactivation of the osteopontin gene enhances vascular calcification of matrix Gla protein-deficient mice: evidence for osteopontin as an inducible inhibitor of vascular calcification in vivo.
Speer MY; McKee MD; Guldberg RE; Liaw L; Yang HY; Tung E; Karsenty G; Giachelli CM
J Exp Med; 2002 Oct; 196(8):1047-55. PubMed ID: 12391016
[TBL] [Abstract][Full Text] [Related]
12. Osteopontin upregulation and polymerization by transglutaminase 2 in calcified arteries of Matrix Gla protein-deficient mice.
Kaartinen MT; Murshed M; Karsenty G; McKee MD
J Histochem Cytochem; 2007 Apr; 55(4):375-86. PubMed ID: 17189522
[TBL] [Abstract][Full Text] [Related]
13. The circulating calcification inhibitors, fetuin-A and osteoprotegerin, but not matrix Gla protein, are associated with vascular stiffness and calcification in children on dialysis.
Shroff RC; Shah V; Hiorns MP; Schoppet M; Hofbauer LC; Hawa G; Schurgers LJ; Singhal A; Merryweather I; Brogan P; Shanahan C; Deanfield J; Rees L
Nephrol Dial Transplant; 2008 Oct; 23(10):3263-71. PubMed ID: 18463323
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical localization and mRNA expression of matrix Gla protein and fetuin-A in bone biopsies of hemodialysis patients.
Coen G; Ballanti P; Silvestrini G; Mantella D; Manni M; Di Giulio S; Pisanò S; Leopizzi M; Di Lullo G; Bonucci E
Virchows Arch; 2009 Mar; 454(3):263-71. PubMed ID: 19151998
[TBL] [Abstract][Full Text] [Related]
15. Early calcification of renal allografts detected by protocol biopsies: causes and clinical implications.
Gwinner W; Suppa S; Mengel M; Hoy L; Kreipe HH; Haller H; Schwarz A
Am J Transplant; 2005 Aug; 5(8):1934-41. PubMed ID: 15996242
[TBL] [Abstract][Full Text] [Related]
16. Circulating levels of osteopontin are related with calcification parameters in patients with renal transplantations.
Karakan S; Sezer S; Özdemir Acar FN; Haberal M
Transplant Proc; 2011 Mar; 43(2):562-4. PubMed ID: 21440761
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and risk factors of vascular calcification in pre-dialysis patients with Balkan endemic nephropathy.
Petković N; Marić R; Gajanin R; Batinić D; Ćuk M; Ristić S; Djukanović L
Srp Arh Celok Lek; 2016; 144(11-12):608-14. PubMed ID: 29659221
[TBL] [Abstract][Full Text] [Related]
18. Expression of bone matrix protein messenger ribonucleic acids in human breast cancers. Possible involvement of osteopontin in development of calcifying foci.
Hirota S; Ito A; Nagoshi J; Takeda M; Kurata A; Takatsuka Y; Kohri K; Nomura S; Kitamura Y
Lab Invest; 1995 Jan; 72(1):64-9. PubMed ID: 7837792
[TBL] [Abstract][Full Text] [Related]
19. Renal handling of matrix Gla-protein in humans with moderate to severe hypertension.
Rennenberg RJ; Schurgers LJ; Vermeer C; Scholte JB; Houben AJ; de Leeuw PW; Kroon AA
Hypertens Res; 2008 Sep; 31(9):1745-51. PubMed ID: 18971553
[TBL] [Abstract][Full Text] [Related]
20. Calcification of human vascular cells in vitro is correlated with high levels of matrix Gla protein and low levels of osteopontin expression.
Proudfoot D; Skepper JN; Shanahan CM; Weissberg PL
Arterioscler Thromb Vasc Biol; 1998 Mar; 18(3):379-88. PubMed ID: 9514406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
